| Date |
Title |
| 24-05-2007 |
SCHWARZ PHARMA Submits Marketing Application for it's Epilepsy compound Lacosamide |
| 10-05-2007 |
FDA Approves SCHWARZ PHARMA's Neupro for the Treatment of early-stage Parkinson's Disease in USA |
| 02-05-2007 |
Jürgen Baumann leaves SCHWARZ PHARMA |
| 25-04-2007 |
First Quarter Report 2007 |
| 16-04-2007 |
SCHWARZ PHARMA Announces Publication of Rotigotine Data for Advanced Parkinson's Disease in Neurology |
| 12-04-2004 |
Rotigotine Study to Investigate 24-hour-Action and Sleep Benefits in Parkinson's Patients |
| 22-03-2007 |
Domination and Profit Transfer Agreement |
| 26-02-2007 |
Full Year Report 2006: Sound Business Trend |
| 15-02-2007 |
Positive Results with Lacosamide in Diabetic Neuropatic Pain in Phase III trial |
| 01-02-2007 |
Changes in the Supervisory Board of SCHWARZ PHARMA |
| 16-01-2007 |
Neupro Now Approved in Europe for All Stages of Parkinson's Disease |
| 11-01-2007 |
Principle Decision on Group Integration of SCHWARZ PHARMA by Domination and Profit Transfer Agreement |
| 11-01-2007 |
Positive Results with Rotigotine in Restless Legs Syndrome in Second Phase III trial |
